Herbalife Ltd. HLF R2KR3K

Q: What is the current share price of Herbalife Ltd. (HLF)?

As of 2026-09-07 16:24 PDT, Herbalife Ltd. (HLF) trades at $12.38 on NYSE. Its 52-week range is $7.75 to $19.96.

Q: What is the market capitalisation of HLF?

Herbalife Ltd. (HLF) has a market capitalisation of $1.30B on NYSE.

Q: What is the P/E ratio of HLF?

HLF trades at a trailing price-to-earnings (P/E) ratio of 7.94. The industry average P/E is 18.74. Its price-to-book (P/B) ratio is -2.48.

Q: What is the return on equity (ROE) of HLF?

HLF has a return on equity (ROE) of -44.32%. Its return on capital employed (ROCE) is 27.13%.

Q: Is HLF a good stock to buy?

This page provides a data-driven analysis of Herbalife Ltd. (HLF), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Consumer Defensive · Packaged Foods · United States

https://www.herbalife.com

Company Profile ↓

$12.38

+26.97% 1Y

Mkt Cap$1.30B

P/E7.94

P/B-2.48

52W High$19.96

52W Low$7.75

Book Value$-4.99

EPS (TTM)$1.56

Company Overview

Herbalife Ltd., together with its subsidiaries, provides health and wellness products in North America, Mexico, South and Central America, Europe, the Middle East, Africa, China, and the Asia Pacific. It offers weight management products, including meal replacement, protein shakes, drink mixes, weight loss supplements, healthy snacks, and metabolism boosting teas; targeted nutrition products comprising functional beverages and dietary and nutritional supplements containing herbs, vitamins, minerals and other natural ingredients; energy, sports, and fitness products; and facial skin care, body care, and hair care products. The company also provides literature, promotional, and other materials, such as start-up kits, sales tools, and educational materials. It sells its products through sales representatives, independent service providers, and company-operated retail stores and platforms. The company was formerly known as Herbalife Nutrition Ltd. and changed its name to Herbalife Ltd. in April 2023. Herbalife Ltd. was founded in 1980 and is headquartered in Los Angeles, California.

Why Investors Should Care

Healthy Capital Returns

Return on capital employed stands at 27.1%.

Reasonable Valuation

Trades at a P/E of 7.9, below the sector median of 18.7.

Positive Free Cash Flow

Generates positive free cash flow, funding growth and shareholder returns internally.

Recent Developments

Dec 2025 Revenue of $5.04B (+0.9% YoY); net profit $228.30M.
Trailing 12 Months Year-on-year growth — revenue +5.4%, earnings -10.2%.
5-Year Trend Long-term compounding — revenue CAGR 4.6%, profit CAGR 0.2%.

Growth & Price Performance

Compounded Sales Growth

5 Years:	4.56%
1 Year:	5.40%

Compounded Profit Growth

5 Years:	0.19%
1 Year:	-10.22%

Stock Price Performance

1 Year:	+26.97%
6 Months:	-19.97%
3 Months:	+8.31%
1 Month:	+7.56%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Mixed

52-Week Range 38% of range

$7.75 $19.96

Trend Signals

Price vs 50-DMAAbove
Price vs 200-DMABelow
RSI (14)51.80 · Neutral

Price Performance

1M+7.56%

3M+8.31%

6M-19.97%

1Y+26.97%

Valuation vs Sector

P/E of 7.94 is below the sector median of 18.74 — relatively cheaper than peers.

Auto-generated from price history and fundamentals; not investment advice.

Price Chart

Robinhood TradingView

Fundamental Growth Charts

Period: Metric:

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

Healthy ROCE of 27.1%.
Generates positive free cash flow.

CONS

Trading 38.0% below its 52-week high.
In a downtrend (50-DMA below 200-DMA).

* The pros and cons are auto-generated from financial metrics.

Valuation

Stock P/E

7.94

Industry PE

18.74

Forward P/E

3.92

PEG Ratio

0.61

Book Value

$-4.99

Price to Book

-2.48

P/S

0.25

EV/EBITDA

5.02

Dividend Yield

0.00%

Growth (CAGR)

Revenue 5Y

4.56%

Profit 5Y

0.19%

Revenue (YoY)

5.40%

Earnings (YoY)

-10.22%

Profitability & Returns

ROCE

27.13%

ROE

-44.32%

ROA

11.27%

Profit Margin

3.16%

Op Margin

9.75%

Gross Margin

77.70%

EPS (Latest Qtr)

$-0.25

EPS (TTM)

$1.56

Balance Sheet & Liquidity

Debt/Equity

Quick Ratio

0.50

Current Ratio

1.20

Debt

$2.20B

Total Assets

$2.86B

Current Assets

$1.14B

Working Capital

$131.80M

Ownership

Promoter Holding

5.01%

Chg in Prom Hold

-0.06%

FII / Inst Holding

101.11%

Chg in FII Hold

0.09%

Financial Snapshot

Enterprise Value

$1.30B

Total Revenue (TTM)

$5.20B

EBITDA

$625.10M

Free Cash Flow

$317.90M

Operating Cash Flow

$383.80M

Shares Outstanding

104.80M

Gross Margin

77.70%

Payout Ratio

0.00%

Peer comparison

Peer companies in the same sector (Consumer Defensive).

#	Name	CMP $	P/E	Mkt Cap	Div Yld %	ROCE %	ROE %	Rev CAGR 5Y %	Profit CAGR 5Y %
1	HLF Herbalife Ltd. R2KR3K	12.38	7.94	$1.30B	0.00%	27.13%	-44.32%	4.56%	0.19%
2	WMT Walmart Inc. SPXR3K	107.14	37.73	$852.63B	0.88%	16.83%	24.13%	3.82%	3.24%
3	COST Costco Wholesale Corporation NDXSPXR3K	915.74	46.16	$406.11B	0.62%	25.96%	29.15%	8.16%	11.45%
4	KO The Coca-Cola Company SPXR3K	88.07	26.45	$378.93B	2.44%	16.47%	42.05%	2.86%	4.46%
5	PG The Procter & Gamble Company SPXR3K	146.44	22.32	$341.00B	2.96%	22.49%	30.29%	0.52%	1.59%
6	PM Philip Morris International Inc. SPXR3K	182.53	25.07	$284.49B	3.13%	34.03%	-113.55%	-1.69%	3.57%
7	PEP PepsiCo, Inc. NDXSPXR3K	137.63	18.04	$188.00B	4.28%	15.41%	51.51%	4.93%	2.11%
8	BUD Anheuser-Busch InBev SA/NV	80.35	17.32	$140.40B	1.61%	8.49%	11.39%	0.88%	4.63%
9	MO Altria Group, Inc. SPXR3K	68.88	14.50	$115.01B	6.26%	38.27%	-	1.24%	-1.89%

Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in USD.

Metric	Jun 2015	Sep 2015	Dec 2015	Mar 2016	Jun 2016	Sep 2016	Dec 2016	Mar 2017	Jun 2017	Sep 2017	Dec 2017	Mar 2018	Jun 2018	Sep 2018	Dec 2018	Mar 2019	Jun 2019	Sep 2019	Dec 2019	Mar 2020	Jun 2020	Sep 2020	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Mar 2022	Jun 2022	Sep 2022	Mar 2023	Jun 2023	Sep 2023	Mar 2024	Jun 2024	Sep 2024	Mar 2025	Jun 2025	Sep 2025	Mar 2026	Jun 2026
Revenue	-	-	-	-	-	-	-	1.10B	1.15B	1.09B	1.09B	1.18B	1.29B	1.24B	1.19B	1.17B	1.24B	1.24B	1.22B	1.26B	1.35B	1.52B	1.41B	1.50B	1.55B	1.43B	1.34B	1.39B	1.30B	1.25B	1.31B	1.28B	1.26B	1.28B	1.24B	1.22B	1.26B	1.27B	1.32B	1.33B
Gross Profit	933.00M	896.00M	894.00M	906.50M	965.50M	912.90M	848.90M	897.50M	928.10M	870.00M	883.50M	937.00M	1.05B	1.02B	960.70M	930.60M	996.90M	1.00B	990.50M	1.02B	1.07B	1.20B	1.10B	1.19B	1.23B	1.13B	1.03B	1.08B	1.01B	953.50M	1.01B	978.10M	979.30M	998.00M	971.60M	956.50M	982.20M	989.50M	1.03B	1.03B
Operating Income	143.80M	161.60M	-	168.30M	-19.90M	151.50M	-	143.80M	204.90M	119.30M	-	155.80M	191.80M	187.30M	-	163.00M	153.10M	143.60M	-	95.60M	189.70M	206.90M	-	222.50M	237.90M	189.40M	153.10M	155.80M	147.40M	70.50M	123.40M	106.70M	71.90M	80.40M	127.10M	122.80M	132.60M	125.80M	138.40M	128.30M
Net Income	82.80M	93.60M	84.50M	95.80M	-22.90M	87.70M	99.40M	85.20M	137.60M	54.50M	-63.40M	82.10M	94.40M	71.20M	48.90M	96.30M	76.50M	81.50M	56.70M	45.60M	115.10M	138.10M	73.80M	147.40M	144.20M	117.40M	98.20M	86.50M	82.20M	29.30M	59.90M	42.80M	24.30M	4.70M	47.40M	50.40M	49.30M	43.20M	61.90M	-26.30M
Diluted EPS	0.97	1.09	0.98	1.12	-0.28	1.01	1.16	0.49	0.81	0.33	-0.43	0.54	0.62	0.49	0.34	0.66	0.54	0.58	0.40	0.32	0.82	1.04	0.59	1.33	1.31	1.09	0.96	0.88	0.83	0.29	0.60	0.43	0.24	0.05	0.46	0.49	0.48	0.42	0.57	-0.25

Profit & Loss (Annual)

Figures in USD.

Metric	Dec 2008	Dec 2009	Dec 2010	Dec 2011	Dec 2012	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Revenue	2.36B	2.32B	2.73B	3.45B	4.07B	4.83B	4.96B	4.47B	4.49B	4.43B	4.89B	4.88B	5.54B	5.80B	5.20B	5.06B	4.99B	5.04B
Gross Profit	1.90B	1.83B	2.18B	2.77B	3.26B	3.86B	3.98B	3.61B	3.63B	3.58B	3.97B	3.92B	4.39B	4.56B	4.03B	3.87B	3.89B	3.92B
Operating Income	332.25M	296.03M	387.51M	562.27M	661.40M	735.30M	513.50M	583.60M	458.10M	617.10M	683.10M	568.10M	640.60M	734.10M	545.20M	356.40M	385.90M	481.00M
Net Income	221.19M	203.35M	299.21M	414.96M	464.00M	527.50M	308.70M	339.10M	260.00M	213.90M	296.60M	311.00M	372.60M	447.20M	321.30M	142.20M	254.30M	228.30M
Diluted EPS	3.36	1.61	2.37	3.32	3.94	4.91	3.40	3.97	1.51	1.29	1.98	2.20	2.77	4.13	3.23	1.42	2.50	2.20

Balance Sheet (Annual)

Figures in USD.

Metric	Dec 2007	Dec 2008	Dec 2009	Dec 2010	Dec 2011	Dec 2012	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Assets	-	-	1.15B	1.23B	1.45B	1.72B	2.47B	2.35B	2.48B	2.57B	2.90B	2.79B	2.68B	3.08B	-	2.73B	2.81B	2.73B	2.79B
Current Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1.36B	1.40B	1.14B	1.14B
Cash & Equivalents	187.41M	150.85M	150.80M	190.55M	258.80M	333.50M	973.00M	645.40M	889.80M	844.00M	1.28B	1.20B	839.40M	1.05B	-	508.00M	575.20M	415.30M	353.10M
Inventory	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	580.70M	505.20M	475.40M	511.70M
Receivables	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	70.60M	81.20M	68.90M	91.90M
Total Liabilities	-	-	786.74M	745.01M	886.02M	1.33B	1.92B	2.69B	2.53B	2.37B	3.23B	3.51B	3.07B	3.93B	-	4.00B	3.87B	3.53B	3.30B
Current Liabilities	-	-	429.97M	470.82M	548.69M	762.36M	922.30M	874.80M	1.02B	791.50M	906.80M	1.59B	964.40M	1.13B	-	976.60M	1.28B	1.23B	1.01B
Long Term Debt	-	-	-	-	-	-	850.00M	1.69B	1.39B	1.44B	2.17B	1.77B	1.78B	2.41B	-	2.66B	2.25B	1.98B	1.97B
Total Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2.92B	2.77B	2.47B	2.18B
Total Equity	182.24M	241.73M	359.31M	474.00M	548.20M	395.50M	551.40M	-334.40M	-53.50M	196.30M	-334.70M	-723.40M	-390.00M	-856.10M	-	-1.27B	-1.06B	-801.10M	-515.10M
Shares Outstanding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	97.90M	99.20M	101.20M	103.31M

Cash Flows (Annual)

Figures in USD.

Metric	Dec 2008	Dec 2009	Dec 2010	Dec 2011	Dec 2012	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Operating Cash Flow	272.99M	285.06M	389.08M	510.54M	567.78M	772.88M	-	-	367.30M	590.80M	648.40M	457.50M	628.60M	460.30M	352.50M	357.50M	285.40M	333.30M
Investing Cash Flow	-84.96M	-71.32M	-69.14M	-92.09M	-125.00M	-150.82M	-	-	-142.40M	-95.20M	-83.90M	-108.00M	-123.20M	-156.40M	-156.20M	-134.80M	-84.60M	-108.70M
Financing Cash Flow	-205.07M	-213.33M	-263.16M	-339.01M	-371.24M	30.74M	-	-	-252.30M	-85.20M	-593.10M	-713.00M	-320.90M	-728.60M	-264.70M	-148.30M	-335.30M	-295.50M
Capital Expenditure	-88.60M	-59.77M	-68.12M	-90.41M	-121.50M	-146.90M	-173.70M	-79.00M	-143.40M	-95.50M	-84.00M	-106.10M	-112.00M	-151.40M	-156.40M	-135.00M	-122.00M	-80.40M
Free Cash Flow	184.39M	225.29M	320.96M	420.13M	446.28M	625.98M	-	-	223.90M	495.30M	564.40M	351.40M	516.60M	308.90M	196.10M	222.50M	163.40M	252.90M
Share Buybacks	138.92M	74.64M	160.01M	321.64M	556.80M	306.50M	1.29B	16.60M	13.20M	844.20M	750.30M	16.70M	923.50M	1.01B	146.70M	11.00M	8.30M	8.20M

Ratios (Annual)

Figures in %.

Metric	Dec 2008	Dec 2009	Dec 2010	Dec 2011	Dec 2012	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Gross Margin %	80.6%	78.8%	79.6%	80.3%	80.0%	80.0%	80.2%	80.8%	81.0%	80.8%	81.2%	80.4%	79.2%	78.6%	77.4%	76.5%	77.9%	77.9%
Operating Margin %	14.1%	12.7%	14.2%	16.3%	16.2%	15.2%	10.4%	13.1%	10.2%	13.9%	14.0%	11.6%	11.6%	12.7%	10.5%	7.0%	7.7%	9.5%
Net Margin %	9.4%	8.7%	10.9%	12.0%	11.4%	10.9%	6.2%	7.6%	5.8%	4.8%	6.1%	6.4%	6.7%	7.7%	6.2%	2.8%	5.1%	4.5%
ROE %	91.5%	56.6%	63.1%	75.7%	117.3%	95.7%	-92.3%	-633.8%	132.5%	-63.9%	-41.0%	-79.7%	-43.5%	-	-25.4%	-13.4%	-31.7%	-44.3%
ROCE %	-	41.3%	50.9%	62.6%	68.8%	47.4%	34.7%	40.2%	25.8%	31.0%	56.9%	33.1%	32.9%	-	31.1%	23.3%	25.8%	27.1%

Shareholding Pattern

Insiders

5.01%

Institutions

101.11%

Public Float

106.44%

Top Institutional Holders

#	Holder	% Held	Shares	Value
1	BAUPOST GROUP LLC/MA	8.84%	9.26M	$115.10M
2	Blackrock Inc.	7.99%	8.37M	$104.05M
3	Route One Investment Company, L.P.	7.97%	8.35M	$103.78M
4	Vanguard Portfolio Management LLC	5.91%	6.19M	$76.97M
5	Renaissance Technologies, LLC	4.79%	5.02M	$62.46M
6	Vanguard Capital Management LLC	4.21%	4.41M	$54.84M
7	Geode Capital Management, LLC	3.31%	3.47M	$43.07M
8	Solel Partners LP	2.72%	2.85M	$35.40M
9	LSV Asset Management	2.50%	2.62M	$32.60M
10	State Street Corporation	2.43%	2.55M	$31.65M

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for HLF

Google News Fri, 28 Aug 2026

Herbalife (HLF) Stock Looks Cheap On Earnings But Weak On Returns - Yahoo Finance

<a href="https://news.google.com/rss/articles/CBMinAFBVV95cUxOMVZqeFo0ZnJNREZqNGhxQVdpT2dDSk5zMUVqempwdWk4OTlYSXRndDZXdGxsU2Z2dlE4LWNsaGxNSXMzOVlfbmlHMlB5RWVQLXNBWjRKd09nRGVGY1NabXRvOHJ5WTBvMEdpSC1nODhVMjZqNXVBcTNqOWtGVTFNTHlGbFE0UEdONTc2X0…

Google News Fri, 04 Sep 2026

Herbalife Stock Price Forecast. Should You Buy HLF? - StockInvest.us

<a href="https://news.google.com/rss/articles/CBMiR0FVX3lxTE9oYW1zUV9tSEdmWmdEZVFRTTRQNno3MnlqcHJKTXdhRE1ZVjJkWHFPZmx2R1E0dnZyOUZsSHFwSjBXSTBnRk9z?oc=5" target="_blank">Herbalife Stock Price Forecast. Should You Buy HLF?</a>  <fon…

Google News ue, 01 Sep 2026

Herbalife (NYSE:HLF) Stock Price Up 5.2% - Should You Buy? - marketbeat.com

<a href="https://news.google.com/rss/articles/CBMisAFBVV95cUxPZ21wQ2l1VjJmbEtDci1TQUFTaGMwdXdwV1IwQ3NZblJwOWZWZW81bWtlcGExclZodTg3ZDFYR0U0MjBnSmxpV0I3T3hpY09MY0ItdXVENnJJZlJXSk1qbGZPX01hWFJfZXV3MFZnT0dqWWx5Ylc2czloOVlISlEwMkJSR210TmY2QWZGOD…

Google News Mon, 31 Aug 2026

Why Herbalife (HLF) Stock Is Nosediving - StockStory

<a href="https://news.google.com/rss/articles/CBMinAFBVV95cUxQaF95a1FmZ08zV2E0SzRyM1JCSTI5NXdab0ZfdGlwZTlJTE91cFBOWWRsZklvb3BLVTNtTTI4TkI2djRHLTlUNmtSbEZaMGdSdGd0MjNmekNfU2t4blhQOVdYRGl1akZ6dFdockxhZm1uZ0lBanJtYWdsTjlOUzNMQXBZV01VVlhVS3lUc0…

Google News Mon, 31 Aug 2026

$HLF stock is down 15% today. Here's what we see in our data. - quiverquant.com

<a href="https://news.google.com/rss/articles/CBMioAFBVV95cUxQTGpWdk9KckJXWGpQODFuRU5NaGNFb3IxbUp2ZjhhemtpYXBWSjI2S3Q4WFF3Qi1ZazBpNl9wenZ1aE9HV0R5aWVkNkI5MGxoRGc5Z084WlF5Wm5TUUJRTjVvYkNDOTN4ajE1cTN4OVFSX1lTcnYtV2RoWGt0WGZreElPcGFBRjB2dHpTan…

Google News hu, 28 May 2026

HLF - Herbalife Ltd Stock Price and Quote - Finviz

<a href="https://news.google.com/rss/articles/CBMiREFVX3lxTE1KREY1WGF2S19SMmg4ZlFXTGRheHQtQVRUdTQyU2hFVENKRnZCQnJfU29nUDhEYXhNblZmMTZMSFB6QkJz?oc=5" target="_blank">HLF - Herbalife Ltd Stock Price and Quote</a>  <font color="#6f6f…

HLF — Frequently Asked Questions

What is the current share price of Herbalife Ltd. (HLF)?

As of 2026-09-07 16:24 PDT, Herbalife Ltd. (HLF) trades at $12.38 on NYSE. Its 52-week range is $7.75 to $19.96.

What is the market capitalisation of HLF?

Herbalife Ltd. (HLF) has a market capitalisation of $1.30B on NYSE.

What is the P/E ratio of HLF?

HLF trades at a trailing price-to-earnings (P/E) ratio of 7.94. The industry average P/E is 18.74. Its price-to-book (P/B) ratio is -2.48.

What is the return on equity (ROE) of HLF?

HLF has a return on equity (ROE) of -44.32%. Its return on capital employed (ROCE) is 27.13%.

Is HLF a good stock to buy?

This page provides a data-driven analysis of Herbalife Ltd. (HLF), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

📊 Consumer Defensive Sector 🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks

Herbalife Ltd. HLF R2KR3K

Company Overview

Why Investors Should Care

Recent Developments

Growth & Price Performance

Compounded Sales Growth

Compounded Profit Growth

Stock Price Performance

Price Chart

Technical Trend

Fundamental Growth Charts

PROS

CONS

Valuation

Growth (CAGR)

Profitability & Returns

Balance Sheet & Liquidity

Ownership

Financial Snapshot

Peer comparison

Quarterly Results

Profit & Loss (Annual)

Balance Sheet (Annual)

Cash Flows (Annual)

Ratios (Annual)

Shareholding Pattern

Top Institutional Holders

Analyst View

Latest News

Herbalife (HLF) Stock Looks Cheap On Earnings But Weak On Returns - Yahoo Finance

Herbalife Stock Price Forecast. Should You Buy HLF? - StockInvest.us

Herbalife (NYSE:HLF) Stock Price Up 5.2% - Should You Buy? - marketbeat.com

Why Herbalife (HLF) Stock Is Nosediving - StockStory

$HLF stock is down 15% today. Here's what we see in our data. - quiverquant.com

HLF - Herbalife Ltd Stock Price and Quote - Finviz

HLF — Frequently Asked Questions

What is the current share price of Herbalife Ltd. (HLF)?

What is the market capitalisation of HLF?

What is the P/E ratio of HLF?

What is the return on equity (ROE) of HLF?

Is HLF a good stock to buy?

Explore More